{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:06:26Z","timestamp":1778558786904,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.vaccine.2009.04.049","type":"journal-article","created":{"date-parts":[[2009,5,10]],"date-time":"2009-05-10T08:52:39Z","timestamp":1241945559000},"page":"4152-4160","source":"Crossref","is-referenced-by-count":33,"title":["Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine"],"prefix":"10.1016","volume":"27","author":[{"given":"Lesley C.","family":"Dupuy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher P.","family":"Locher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madan","family":"Paidhungat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle J.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathleen M.","family":"Lind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell","family":"Bakken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G.","family":"Whalen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie S.","family":"Schmaljohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.04.049_bib1","series-title":"Fields virology","first-page":"843","article-title":"Alphaviruses","author":"Johnston","year":"1996"},{"issue":"3","key":"10.1016\/j.vaccine.2009.04.049_bib2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0272-2712(18)30018-0","article-title":"Clinical recognition and management of patients exposed to biological warfare agents","volume":"21","author":"Franz","year":"2001","journal-title":"Clin Lab Med"},{"issue":"1","key":"10.1016\/j.vaccine.2009.04.049_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0025-7125(16)30270-X","article-title":"Viral encephalitis","volume":"77","author":"Bale","year":"1993","journal-title":"Med Clin North Am"},{"issue":"1","key":"10.1016\/j.vaccine.2009.04.049_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0891-5520(20)30389-5","article-title":"Arboviral infections in the United States","volume":"5","author":"Tsai","year":"1991","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.vaccine.2009.04.049_bib5","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4269\/ajtmh.1963.12.597","article-title":"Use of an attenuated strain of Venezuelan equine encephalomyelitis virus for immunization in man","volume":"12","author":"McKinney","year":"1963","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.vaccine.2009.04.049_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0264-410X(95)00168-Z","article-title":"Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine","volume":"14","author":"Pittman","year":"1996","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.04.049_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1128\/JCM.19.3.429-431.1984","article-title":"Protective efficacies of live attenuated and formalin-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters","volume":"19","author":"Jahrling","year":"1984","journal-title":"J Clin Microbiol"},{"issue":"25","key":"10.1016\/j.vaccine.2009.04.049_bib8","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1016\/S0264-410X(03)00362-1","article-title":"Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus","volume":"21","author":"Riemenschneider","year":"2003","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2009.04.049_bib9","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1186\/gb-2002-3-8-reviews1021","article-title":"Anticipatory evolution and DNA shuffling","volume":"3","author":"Bacher","year":"2002","journal-title":"Genome Biol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.04.049_bib10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0958-1669(00)00228-7","article-title":"Advances in directed protein evolution by recursive genetic recombination: applications to therapeutic proteins","volume":"12","author":"Kurtzman","year":"2001","journal-title":"Curr Opin Biotechnol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.04.049_bib11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1359-6446(02)02590-4","article-title":"Optimization of protein therapeutics by directed evolution","volume":"8","author":"Vasserot","year":"2003","journal-title":"Drug Discov Today"},{"issue":"6664","key":"10.1016\/j.vaccine.2009.04.049_bib12","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/34663","article-title":"DNA shuffling of a family of genes from diverse species accelerates directed evolution","volume":"391","author":"Crameri","year":"1998","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.vaccine.2009.04.049_bib13","doi-asserted-by":"crossref","first-page":"10747","DOI":"10.1073\/pnas.91.22.10747","article-title":"DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution","volume":"91","author":"Stemmer","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6488","key":"10.1016\/j.vaccine.2009.04.049_bib14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/370389a0","article-title":"Rapid evolution of a protein in vitro by DNA shuffling","volume":"370","author":"Stemmer","year":"1994","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2009.04.049_bib15","first-page":"34","article-title":"Development of novel vaccines using DNA shuffling and screening strategies","volume":"6","author":"Locher","year":"2004","journal-title":"Curr Opin Mol Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2009.04.049_bib16","first-page":"31","article-title":"DNA shuffling and vaccines","volume":"3","author":"Whalen","year":"2001","journal-title":"Curr Opin Mol Ther"},{"issue":"4","key":"10.1016\/j.vaccine.2009.04.049_bib17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1517\/14712598.4.4.589","article-title":"Overcoming antigenic diversity and improving vaccines using DNA shuffling and screening technologies","volume":"4","author":"Locher","year":"2004","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"10.1016\/j.vaccine.2009.04.049_bib18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.vaccine.2005.07.100","article-title":"Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen","volume":"24","author":"Apt","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2009.04.049_bib19","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1089\/dna.2005.24.256","article-title":"DNA shuffling and screening strategies for improving vaccine efficiency","volume":"24","author":"Locher","year":"2005","journal-title":"DNA Cell Biol"},{"issue":"1-3","key":"10.1016\/j.vaccine.2009.04.049_bib20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0165-022X(01)00213-5","article-title":"The FLAG peptide, a versatile fusion tag for the purification of recombinant proteins","volume":"49","author":"Einhauer","year":"2001","journal-title":"J Biochem Biophys Methods"},{"issue":"2","key":"10.1016\/j.vaccine.2009.04.049_bib21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/0042-6822(90)90533-W","article-title":"Variants of Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein","volume":"177","author":"Johnson","year":"1990","journal-title":"Virology"},{"issue":"9-10","key":"10.1016\/j.vaccine.2009.04.049_bib22","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0264-410X(98)00335-1","article-title":"Expression, processing, and immunogenicity of the structural proteins of Venezuelan equine encephalitis virus from recombinant baculovirus vectors","volume":"17","author":"Hodgson","year":"1999","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2009.04.049_bib23","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1517\/14712598.4.6.889","article-title":"Particle-mediated DNA vaccine delivery to the skin","volume":"4","author":"Haynes","year":"2004","journal-title":"Expert Opin Biol Ther"},{"issue":"12","key":"10.1016\/j.vaccine.2009.04.049_bib24","doi-asserted-by":"crossref","first-page":"9563","DOI":"10.1128\/JVI.71.12.9563-9569.1997","article-title":"Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge","volume":"71","author":"Schmaljohn","year":"1997","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.04.049_bib25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0264-410X(96)00204-6","article-title":"Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB\/c, but not C3H\/HeN mice","volume":"15","author":"Hart","year":"1997","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.04.049_bib26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0042-6822(85)90343-5","article-title":"The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes","volume":"142","author":"Roehrig","year":"1985","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2009.04.049_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/08830189409061720","article-title":"Immunogenicity of viral B- and T-cell epitopes expressed in recombinant bacterial proteins","volume":"11","author":"Leclerc","year":"1994","journal-title":"Int Rev Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.04.049_bib28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0264-410X(00)00123-7","article-title":"An immunological profile of Balb\/c mice protected from airborne challenge following vaccination with a live attenuated Venezuelan equine encephalitis virus vaccine","volume":"19","author":"Bennet","year":"2000","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.04.049_bib29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0264-410X(95)93315-Z","article-title":"Localization of a protective epitope on a Venezuelan equine encephalomyelitis (VEE) virus peptide that protects mice from both epizootic and enzootic VEE virus challenge and is immunogenic in horses","volume":"13","author":"Hunt","year":"1995","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.04.049_bib30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0168-1702(02)00275-7","article-title":"Cytotoxic T-cell activity is not detectable in Venezuelan equine encephalitis virus-infected mice","volume":"91","author":"Jones","year":"2003","journal-title":"Virus Res"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2009.04.049_bib31","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0264-410X(01)00505-9","article-title":"Monoclonal antibody protects mice against infection and disease when given either before or up to 24h after airborne challenge with virulent Venezuelan equine encephalitis virus","volume":"20","author":"Philpotts","year":"2002","journal-title":"Vaccine"},{"issue":"5861","key":"10.1016\/j.vaccine.2009.04.049_bib32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/297070a0","article-title":"Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis","volume":"297","author":"Schmaljohn","year":"1982","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.vaccine.2009.04.049_bib33","doi-asserted-by":"crossref","first-page":"11645","DOI":"10.1128\/JVI.76.22.11645-11658.2002","article-title":"Placement of the structural proteins in Sindbis virus","volume":"76","author":"Zhang","year":"2002","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.04.049_bib34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.virol.2007.01.006","article-title":"Functional characterization of the Sindbis virus E2 glycoprotein by transposon linker-insertion mutagenesis","volume":"363","author":"Navaratnarajah","year":"2007","journal-title":"Virology"},{"issue":"9-10","key":"10.1016\/j.vaccine.2009.04.049_bib35","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0264-410X(97)00192-8","article-title":"Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates","volume":"16","author":"Pratt","year":"1998","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09006033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09006033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T04:33:39Z","timestamp":1633408419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09006033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":35,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0264410X09006033"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.04.049","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}